Skip to main content
Premium Trial:

Request an Annual Quote

Bulldog Bio to Sell GeneWorks' Cloning Technology in US

NEW YORK (GenomeWeb News) – Bulldog Bio today said that it has been given the exclusive rights to sell Australian firm GeneWorks's Acquire PCR Cloning technology in the US.

"The technology incorporated into the Acquire PCR Cloning Kit will provide our customers with the potential for extraordinary results from both A-tailed and blunt-ended PCR products, without the need for color selection," Ella Fontaine, vice president of communication for Bulldog Bio, said in a statement. "The Acquire kit's novel feature set, including a unique vector with three base overhang, enables rapid and efficient cloning, and the attractive price should make it one of our most popular products."

Terms of the deal were not disclosed.

Bulldog, based in Portsmouth, NH, distributes tools to life science researchers. GeneWorks, headquartered in Adelaide, Australia, supplies molecular biology research products and services.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.